
Synthetic biology startup StrainX raises $13 million in funding from Prime Venture Partners, Leo Capital - Moneycontrol.com
StrainX is a synthetic biology startup focused on developing innovative solutions in the field of biotechnology. The company aims to leverage advanced biological engineering techniques to create new products and processes. This funding round will help StrainX accelerate its growth and expand its research capabilities.
Synthetic biology startup StrainX raises $13 million in funding from Prime Venture Partners, Leo Capital Moneycontrol.com
| Jun 11, 2026 | Record OS | $2.0M | Pre-seed | — |
| Jun 09, 2026 | Nacional Financiera (NAFIN) | $57.3M | Debt | Mexico |
| Jun 09, 2026 | Vinyl Equity | $20.0M | — | United States |
| Jun 09, 2026 | Merchantee | $1.9M | — | — |